miRview® meso is a cutting-edge molecular diagnostic test that uses microRNA to differentiate malignant pleural mesothelioma from peripheral adenocarcinomas of the lung or metastatic carcinomas involving the lung and pleura. Unlike other diagnostic tools currently available, miRview® meso provides a differential diagnosis with:

• Accuracy (the sensitivity and specificity of miRview® meso have been shown to be 100% and 94%, respectively¹)
• Simple interpretation
• Routine sample preparation

1. Data on file, Rosetta Genomics.